Clinical Trial Update: Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) versus maintaining TDF in chronic hepatitis B with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Tenofovir alafenamide (TAF) (Tenofovir alafenamide)
• tenofovir disoproxil fumarate (TDF) (tenofovir disoproxil fumarate)

Snippet

Sponsor: Young-Suk Lim | Conditions: Chronic Hepatitis b | Phase 4 | Status: COMPLETED